Sepsis resident survival guide

Revision as of 01:44, 26 February 2014 by Gonzalo Romero (talk | contribs)
Jump to navigation Jump to search

Sepsis Microchapters

Home

Patient Information (Adult)

Patient Information (Neonatal)

Overview

Pathophysiology

Causes

Differentiating Sepsis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sepsis resident survival guide On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sepsis resident survival guide

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sepsis resident survival guide

CDC on Sepsis resident survival guide

Sepsis resident survival guide in the news

Blogs on Sepsis resident survival guide

Directions to Hospitals Treating Sepsis

Risk calculators and risk factors for Sepsis resident survival guide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Definition

  • Sepsis = Infection + SIRS
  • The presence of systemic inflammatory syndrome (SIRS) is due to many factors. The presence of infection increases the chances of sepsis and increase the SIRS criteria .
  • The endothelial dysfunction is the main trigger transforming the localized infection into systemic organ dysfunction
  • There is no definitive biomarkers have been associated with the endothelial dysfunction of sepsis.

SIRS is diagnosed by 2 or more of the following:

Sepsis is diagnosed by at least 1 of the following signs of organ failure: [HOME]

  • Hypoxemia (arterial oxygen tension [PaO2] < 72 mm Hg at fraction of inspired oxygen [FiO2] 0.21; overt pulmonary disease not the direct cause of hypoxemia)
  • Oiguria (urine output < 30 mL or 0.5 mL/kg for at least 1 h)
  • Mental status alteration
  • Elevated plasma lactate level > 4 mmol/L

Severe sepsis

  • Sepsis + organ dysfunction
  • Organ damage can present as decreased urine output, acute kidney injury, and elevated liver function tests.

Septic shock

  • Severe sepsis + persistent hypotension after adequate fluid challenge.

Multiple organ dysfunction syndrome (MODS) is the presence of altered organ function in a acutely ill patient whom homeostasis cannot be maintained without intervention.

Diagnostic Criteria For Sepsis (Documented/Suspected Infection Plus Inflammatory variablesPlus One of The Organ Dysfunction)


General variables
  • Fever > 38.3°C
  • Hypothermia ( core temperature < 36°C )
  • Heart rate > 90/min–1 or > 2 SD above the normal value for age
  • Tachypnea
  • Altered mental status
  • Edema
  • Positive fluid balance ( > 20 mL/kg over 24 hr)
  • Hyperglycemia ( plasma glucose > 140 mg/dL or 7.7 mmol/L ) in the absence of diabetes
Inflammatory variables
  • Leukocytosis ( WBC count > 12,000 µL–1 )
  • Leukopenia ( WBC count < 4000 µL–1 )
  • Immature WBCs forms are > 10% with normal count
  • Plasma C-reactive protein > 2 SD above the normal value
  • Plasma procalcitonin > 2 SD above the normal value
  • Hemodynamic variables
  • Arterial hypotension after 30 ml/kg fluid bolus ( SBP < 90 mm Hg, MAP < 70 mm Hg, or an SBP decrease > 40 mm Hg in adults or < 2 SD below normal for age )
Organ dysfunction variables
  • Arterial hypoxemia ( Pao2/Fio2 < 300 )
  • Acute oliguria ( urine output < 0.5 mL/kg/hr for at least 2 hrs despite adequate fluid resuscitation )
  • Creatinine increase > 0.5 mg/dL or 44.2 µmol/L
  • Coagulation abnormalities ( INR > 1.5 or aPTT > 60 Sec )
  • Ileus ( absent bowel sounds )
  • Thrombocytopenia ( platelet count < 100,000 µL–1 )
  • Hyperbilirubinemia ( plasma total bilirubin > 4 mg/dL or 70 µmol/L )
  • Tissue perfusion variables
  • Hyperlactatemia > 1 mmol/L
  • Decreased capillary refill or mottling
  • Evidence of acute lung injury (ALI):[1]
  1. Oxygenation abnormality with a PaO2/FiO2 ratio < 300
  2. Chest Xray with bilateral opacities compatible with pulmonary edema
  3. PA < 18 mm Hg or no clinical evidence of left atrial hypertension if PaO2 is not available
  • Acute respiratory distress syndrome (ARDS) is a more severe form of ALI and is defined similarly but a characteristic PaO2/FiO2 ratio is < 200

Causes

Life Threatening Causes

  • Bacteremia: 95% of positive blood cultures were associated with sepsis, severe sepsis, or septic shock.[2]. However septic shock can occur without bacteremia "viable bacteria in the blood". In fact, septic shock is associated with culture-positive bacteremia in only 30-50% of cases.[3][4][5][6]

Common Causes

  • Community acquired pneumonia: 48% develop severe sepsis.[7]
  • Diabetes and renal disease may explain the higher rates of infection related septic shock.
  • Immunosuppression

Prognosis

  • Advanced age > 65 year old: a strong correlation exists between the incidence of septic shock in patients older than 50 years.
  • Organ dysfunction is more related to bad prognosis than meeting SIRS criteria. A study found that just meeting SIRS criteria without evidence of organ dysfunction did not predict increased mortality. This concludes the importance of identification of organs dysfunction over the presence of SIRS criteria.[8]

Management

Goals during the first six hours of fluid resuscitation, as suggested by the Surviving Sepsis Campaign guidelines, include the following:[9]

  • CVP 8-12 mmHg
  • SCVo2 (superior vena cava) 70% or SVo2 65%
  • MAP ≥ 65 mmHg
  • Urine output ≥ 0.5 mL/kg/hour
 
 
 
 
 
Sepsis screening
Patient identification
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
History of infection
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes, history of infection
 
 
 
 
 
No History
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes,Clinical symptoms
 
 
 
 
 
No clinical symptoms
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Activate Sepsis Protocol
Blood culture 2X,
then early antibiotics within 1 hr
Check lactate elevation, evidence of organ dysfunction
 
 
 
 
 
No lactate
No evidence of organ dysfunction
Normal tissue perfusion
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tissue hypoperfusion
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes, Tissue hypoperfusion
 
No tissue hypoperfusion
 
 
 
 
 
 
 
 
 
 
 
 
SBO ≤ 90mm Hg
MAP ≤ 65 mm Hg
Lactate ≥ 4mmol/L
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protocol A and B
 
Protocol B
 




}}
 
 
 
 
PROTOCOL A
Sepsis-induced Hypoperfusion
Clinical picture plus
< 65mm Hg
Lactate > 4mmol/L
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental O2 (Targeted by O2)
Fluid resuscitation at least crystalloid bolus or
colloid equivalent 20ml/kg
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CVP measurement
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CVP < 8mm Hg
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Crystalloid bolus or colloid equivalent till CVP > 8 mm Hg
 
 
 
CVP > 8mm Hg
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MAP
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MAP < 65 mmHg
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vasopressors
( 1st line Norepinephrine 0.05 mcg/kg/min )
( 2nd line Dopamine / Vasopressin )
(3rd-4th line Phenylephrine ) till MAP > 65 mmHg
 
 
 
MAP > 65 mmHg
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SeVO2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SeVO2 < 70%
 
 
 
SeVO2 > 70%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Transfuse PRBCs,
if HCT ≤ 30
Dobutamine
if HCT > 30
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Goals achieved
 
 
 
Goals achieved
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Resuscitation completed
Reevaluate
 
 
Vasopressors still required
Stress Dose Steroids
 
 




 
 
 
 
 
 
 
PROTOCOL B
Sepsis shock with NO tissue hypoperfusion
Normal Perfusion
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assess requirement for Mechanical ventilation (Targeted by O2)
 
Infection source identification
Empirical antibiotics after 2 blood cultures
 
 
Plasma glucose level
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mechanical ventilation required
 
 
No mechanical ventilation required
 
 
< 180 mg/dl
maintain < 150 mg/dl
 
 
> 180 mg/dl
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Semi Recumbent position
Lung-protective ventilation for ALI/ARDS
Maintain intermittent positive pressure (IPPP) < 30 cm H2o
 
 
 
 
 
 
 
 
 
 
Start insulin to keep glucose < 150

Do's

Do within 3 Hours

  1. Measure lactate level.
  2. Obtain at least 2 sets of blood cultures and cultures of other relevant sites, provided it does not cause a delay exceeding 45 minutes in starting antimicrobial therapy.
  3. Administer broad spectrum antibiotics at least 1 drug with activity against all likely pathogens ( bacterial, fungal, or viral )
  4. Administer adequate fluid challenge (40-60 mL/kg) crystalloid for hypotension or lactate 4 mmol/L.
  5. Maintian CVP 8-12 cm H2o in non-intubated patients, and CVP 12-15 cm H2o for intubated patients.

Do within 6 Hours

  1. Apply vasopressors in hypotension refractory to initial fluid resuscitation.
  2. Maintain a mean arterial pressure (MAP) ≥ 65 mm Hg.
  3. In persistent arterial hypotension despite volume resuscitation or initial lactate 4 mmol/L ( 36 mg/dL ): check CVPand ScvO2.
  4. Re-measure lactate if initial lactate was elevated.
  5. Initiating broad-spectrum coverage until the specific organism is cultured and antibiotic sensitivities are determined is important.

Don'ts

  • Routine use of hemodynamic drugs to raise cardiac output to supranormal levels is not recommended.
  • Increasing the cardiac index in order to enhance the oxygen delivery has no improvement on outcome but it has worsened morbidity and mortality.
  • Administration of bicarbonate in order to correct the acidosis may worsen the intracellular acidosis. Correction of acidemia with sodium bicarbonate has not been proved to improve hemodynamics in a critically ill patient with increased blood lactate levels.
  • Immunosuppressive agents that could suppress the overwhelming inflammatory mediators responsible for MODs, as high-dose corticosteroids, have not shown any benefit in humans. However the encouraging data from animal studies.
  • Unfractionated heparin in patients with sepsis did not have any beneficial effect on length of hospital stay, MODs, and mortality compared to placebo.[10]

References

  1. Bernard, GR.; Artigas, A.; Brigham, KL.; Carlet, J.; Falke, K.; Hudson, L.; Lamy, M.; Legall, JR.; Morris, A. (1994). "The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination". Am J Respir Crit Care Med. 149 (3 Pt 1): 818–24. doi:10.1164/ajrccm.149.3.7509706. PMID 7509706. Unknown parameter |month= ignored (help)
  2. Jones, GR.; Lowes, JA. (1996). "The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis". QJM. 89 (7): 515–22. PMID 8759492. Unknown parameter |month= ignored (help)
  3. Brun-Buisson, C.; Doyon, F.; Carlet, J.; Dellamonica, P.; Gouin, F.; Lepoutre, A.; Mercier, JC.; Offenstadt, G.; Régnier, B. (1995). "Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis". JAMA. 274 (12): 968–74. PMID 7674528. Unknown parameter |month= ignored (help)
  4. Sands, KE.; Bates, DW.; Lanken, PN.; Graman, PS.; Hibberd, PL.; Kahn, KL.; Parsonnet, J.; Panzer, R.; Orav, EJ. (1997). "Epidemiology of sepsis syndrome in 8 academic medical centers". JAMA. 278 (3): 234–40. PMID 9218672. Unknown parameter |month= ignored (help)
  5. Kumar, A.; Roberts, D.; Wood, KE.; Light, B.; Parrillo, JE.; Sharma, S.; Suppes, R.; Feinstein, D.; Zanotti, S. (2006). "Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock". Crit Care Med. 34 (6): 1589–96. doi:10.1097/01.CCM.0000217961.75225.E9. PMID 16625125. Unknown parameter |month= ignored (help)
  6. Bernard, GR.; Vincent, JL.; Laterre, PF.; LaRosa, SP.; Dhainaut, JF.; Lopez-Rodriguez, A.; Steingrub, JS.; Garber, GE.; Helterbrand, JD. (2001). "Efficacy and safety of recombinant human activated protein C for severe sepsis". N Engl J Med. 344 (10): 699–709. doi:10.1056/NEJM200103083441001. PMID 11236773. Unknown parameter |month= ignored (help)
  7. Dremsizov, T.; Clermont, G.; Kellum, JA.; Kalassian, KG.; Fine, MJ.; Angus, DC. (2006). "Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course?". Chest. 129 (4): 968–78. doi:10.1378/chest.129.4.968. PMID 16608946. Unknown parameter |month= ignored (help)
  8. Shapiro, N.; Howell, MD.; Bates, DW.; Angus, DC.; Ngo, L.; Talmor, D. (2006). "The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection". Ann Emerg Med. 48 (5): 583–90, 590.e1. doi:10.1016/j.annemergmed.2006.07.007. PMID 17052559. Unknown parameter |month= ignored (help)
  9. Dellinger, RP.; Levy, MM.; Rhodes, A.; Annane, D.; Gerlach, H.; Opal, SM.; Sevransky, JE.; Sprung, CL.; Douglas, IS. (2013). "Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012". Intensive Care Med. 39 (2): 165–228. doi:10.1007/s00134-012-2769-8. PMID 23361625. Unknown parameter |month= ignored (help)
  10. Jaimes, F.; De La Rosa, G.; Morales, C.; Fortich, F.; Arango, C.; Aguirre, D.; Muñoz, A. (2009). "Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study)". Crit Care Med. 37 (4): 1185–96. doi:10.1097/CCM.0b013e31819c06bc. PMID 19242322. Unknown parameter |month= ignored (help)

Template:WH Template:WS